Vascular sequelae following SARS-CoV-2 coronavirus disease COVID-19 infection are considered as Long Covid disease, when occurring 12 weeks after the original infection. The paucity of specific data can be obviated by translating pathophysiological elements from the original Severe Acute Respiratory Syndrome-Corona Virus infection. In a microcirculatory system, a first endotheliitis, is often followed by production of Neutrophil Extracellular Trap, and can evolve into a more complex leukocytoklastic-like and hyperimmune vasculitis. In medium/large-sized vessels, this corresponds to endothelial dysfunction, leading to an accelerated progression of pre-existing atherosclerotic plaques through an increased deposition of platelets, circulating inflammatory cells and proteins. Associated dysregulated immune and pro-coagulant conditions can directly cause thrombo-embolic arterial or venous complications. In order to implement appropriate treatment, physicians need to consider vascular pathologies observed after SARS-Cov-2 infections as possible LC disease.
Zanini, G., Selleri, V., Roncati, L., Coppi, F., Nasi, M., Farinetti, A., et al. (2024). Vascular "Long COVID": A New Vessel Disease?. ANGIOLOGY, 75(1), 8-14 [10.1177/00033197231153204].
Vascular "Long COVID": A New Vessel Disease?
Mattioli, Anna Vittoria
Ultimo
Membro del Collaboration Group
2024
Abstract
Vascular sequelae following SARS-CoV-2 coronavirus disease COVID-19 infection are considered as Long Covid disease, when occurring 12 weeks after the original infection. The paucity of specific data can be obviated by translating pathophysiological elements from the original Severe Acute Respiratory Syndrome-Corona Virus infection. In a microcirculatory system, a first endotheliitis, is often followed by production of Neutrophil Extracellular Trap, and can evolve into a more complex leukocytoklastic-like and hyperimmune vasculitis. In medium/large-sized vessels, this corresponds to endothelial dysfunction, leading to an accelerated progression of pre-existing atherosclerotic plaques through an increased deposition of platelets, circulating inflammatory cells and proteins. Associated dysregulated immune and pro-coagulant conditions can directly cause thrombo-embolic arterial or venous complications. In order to implement appropriate treatment, physicians need to consider vascular pathologies observed after SARS-Cov-2 infections as possible LC disease.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.